Cargando…
A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study
BACKGROUND: The global pandemic has caused breast cancer (BC) patients who are receiving chemotherapy to face more challenges in taking care of themselves than usual. A novel nurse-led mHealth program (mChemotherapy) is designed to foster self-management for this population. The aim of the pilot stu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358201/ https://www.ncbi.nlm.nih.gov/pubmed/35921175 http://dx.doi.org/10.1177/10732748221115469 |
_version_ | 1784763876828512256 |
---|---|
author | Shi, Nuo Wong, Arkers K. C. Wong, Frances K. Y. Zhang, Nan Lai, Xiaobin Gan, Lu |
author_facet | Shi, Nuo Wong, Arkers K. C. Wong, Frances K. Y. Zhang, Nan Lai, Xiaobin Gan, Lu |
author_sort | Shi, Nuo |
collection | PubMed |
description | BACKGROUND: The global pandemic has caused breast cancer (BC) patients who are receiving chemotherapy to face more challenges in taking care of themselves than usual. A novel nurse-led mHealth program (mChemotherapy) is designed to foster self-management for this population. The aim of the pilot study is to determine the feasibility, usability, and acceptability of an mChemotherapy program for breast cancer patients undergoing chemotherapy. The objective also is to evaluate the preliminary effects of this program on adherence to app usage, self-efficacy, quality of life, symptom burden, and healthcare utilization among this group of patients. METHODS: This is a single-blinded randomized controlled pilot study that includes one intervention group (mChemotherapy group) and one control group (routine care group). Ninety-four breast cancer patients who commence chemotherapy in a university-affiliated hospital will be recruited. Based on the Individual and Family Self-management Theory, this 6-week mChemotherapy program, which includes a combination of self-regulation activities and nurse-led support, will be provided. Data collection will be conducted at baseline, week 3 (T1), and week 6 (T2). A general linear model will be utilized for identifying the between-group, within-group, and interaction effects. Qualitative content analysis will be adopted to analyze, extract, and categorize the interview transcripts. DISCUSSIONS: Breast cancer patients receiving chemotherapy are a population that often experiences a heavy symptom burden. During the pandemic, they have had difficulties in self-managing the side effects of chemotherapy due to the lack of face-to-face professional support. An mChemotherapy program will be adopted through a self-regulation process and with the provision of nurse-led real-time professional support for these patients. If proven effective, BC patients who engage in this program will be more likely to take an active role in managing their symptoms, take responsibility for their own health, and subsequently improve their self-efficacy and adherence to the use of the app. |
format | Online Article Text |
id | pubmed-9358201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-93582012022-08-10 A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study Shi, Nuo Wong, Arkers K. C. Wong, Frances K. Y. Zhang, Nan Lai, Xiaobin Gan, Lu Cancer Control Study Protocol BACKGROUND: The global pandemic has caused breast cancer (BC) patients who are receiving chemotherapy to face more challenges in taking care of themselves than usual. A novel nurse-led mHealth program (mChemotherapy) is designed to foster self-management for this population. The aim of the pilot study is to determine the feasibility, usability, and acceptability of an mChemotherapy program for breast cancer patients undergoing chemotherapy. The objective also is to evaluate the preliminary effects of this program on adherence to app usage, self-efficacy, quality of life, symptom burden, and healthcare utilization among this group of patients. METHODS: This is a single-blinded randomized controlled pilot study that includes one intervention group (mChemotherapy group) and one control group (routine care group). Ninety-four breast cancer patients who commence chemotherapy in a university-affiliated hospital will be recruited. Based on the Individual and Family Self-management Theory, this 6-week mChemotherapy program, which includes a combination of self-regulation activities and nurse-led support, will be provided. Data collection will be conducted at baseline, week 3 (T1), and week 6 (T2). A general linear model will be utilized for identifying the between-group, within-group, and interaction effects. Qualitative content analysis will be adopted to analyze, extract, and categorize the interview transcripts. DISCUSSIONS: Breast cancer patients receiving chemotherapy are a population that often experiences a heavy symptom burden. During the pandemic, they have had difficulties in self-managing the side effects of chemotherapy due to the lack of face-to-face professional support. An mChemotherapy program will be adopted through a self-regulation process and with the provision of nurse-led real-time professional support for these patients. If proven effective, BC patients who engage in this program will be more likely to take an active role in managing their symptoms, take responsibility for their own health, and subsequently improve their self-efficacy and adherence to the use of the app. SAGE Publications 2022-08-03 /pmc/articles/PMC9358201/ /pubmed/35921175 http://dx.doi.org/10.1177/10732748221115469 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Study Protocol Shi, Nuo Wong, Arkers K. C. Wong, Frances K. Y. Zhang, Nan Lai, Xiaobin Gan, Lu A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study |
title | A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study |
title_full | A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study |
title_fullStr | A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study |
title_full_unstemmed | A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study |
title_short | A Nurse-Led mHealth Self-Management Program (mChemotherapy) for Breast Cancer Patients Undergoing Chemotherapy: Study Protocol of a Randomized Controlled Pilot Study |
title_sort | nurse-led mhealth self-management program (mchemotherapy) for breast cancer patients undergoing chemotherapy: study protocol of a randomized controlled pilot study |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358201/ https://www.ncbi.nlm.nih.gov/pubmed/35921175 http://dx.doi.org/10.1177/10732748221115469 |
work_keys_str_mv | AT shinuo anurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT wongarkerskc anurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT wongfrancesky anurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT zhangnan anurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT laixiaobin anurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT ganlu anurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT shinuo nurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT wongarkerskc nurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT wongfrancesky nurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT zhangnan nurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT laixiaobin nurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy AT ganlu nurseledmhealthselfmanagementprogrammchemotherapyforbreastcancerpatientsundergoingchemotherapystudyprotocolofarandomizedcontrolledpilotstudy |